Southeast University, China: Sepsis trials
The registry lists 17 Sepsis studies with Southeast University, China as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 3 2Phase 4 2No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Outer Membrane Vesicle and Ferroptosis-Related Signatures in Sepsis-Associated Acute Lung Injury Caused by Extra-Pulmonary Hypervirulent Klebsiella PneumoniaeNot yet recruitingNCT07686887
- Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled TrialRecruitingNCT07576660Phase 3
- Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）Not yet recruitingNCT07069894
- Outcomes of Sepsis Patients in China (CHINA-SEP)Not yet recruitingNCT07066553
- Novel Biomarkers Related Xuebijing Injection Improves SepsisNot yet recruitingNCT06920420
- The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDSNot yet recruitingNCT06063707
- Effect of Immunophenotype on Prognosis of SepsisStatus unknownNCT05602584
- Co-inhibitory Molecules on Treg and miR-155-5p in Patients With SepsisStatus unknownNCT05126537
- Protective Effect of Sivelestat Sodium on ARDS in Patients With SepsisStatus unknownNCT04973670Phase 3
- A Multiple Centre, Cohort Study of New CRRT Membranes oXiris for Patients With Septic ShockCompletedNCT04073771
- Pharmacokinetics of XueBiJing in Patients With SepsisCompletedNCT03475732Not applicable
- Dissecting How Peripheral Lymphocytes Are Lost During SepsisStatus unknownNCT03289312
- The Efficacy of Xuebijing Injection on SepsisCompletedNCT03238742Phase 4
- The Effects of SGC on Glucose Control in Critically Ill Patients With SepsisStatus unknownNCT02980588Not applicable
- Predictive Value of Dynamic Combination of BNP and NGAL for the Prognosis of Patients With SepsisCompletedNCT02871544Not applicable
- Preliminary Research On Two-step Dosing Of Imipenem/CilastatinStatus unknownNCT02616354Phase 4
- Midkine and ACE-Ang II Induced Endothelial Injury in SepsisCompletedNCT02605681